4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-20-000035
President and CEO acquired 26,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Luly Jay R. · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-11-20 | Grant or award : show line 1 in the form | +26,500 | 676,189 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-11-20 | Grant or award : show line 2 in the form Stock Option (right to buy) | +107,800 | 107,800 | D |
Loading xslF345X03/edgar.xml…